Research analysts at Zacks Research cut their Q3 2027 EPS estimates for Haemonetics in a note issued to investors on Wednesday, January 29th. Zacks Research analyst R. Department now forecasts that ...

Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. How do you find the right combination ...

Zacks Small-Cap Core Fund earns an Average Process Pillar rating. The main contributor to the rating is the fund's impressive long-term risk-adjusted performance. This can be seen in its ten-year ...

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor. But how do you find the right combination of stocks?

Investment analysts at Zacks Research decreased their FY2024 earnings per share (EPS) estimates for Intercontinental Exchange in a report issued on Tuesday, January 28th. Zacks Research analyst T. De ...

Chicago, IL – January 27, 2025 – Zacks.com releases the list of companies likely to issue earnings surprises. This week’s ...

Shares of AbbVie ( ABBV 6.95%) were jumping 7.1% higher as of 11:10 a.m. ET on Friday after rising as much as 9.2% earlier in ...

President Trump also rolled out a significant AI infrastructure investment exceeding $500 billion, a shot in the arm for the ...

AbbVie Inc. (ABBV) on Friday reported a fourth-quarter loss of $22 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Roswell, Georgia-based company said it had net income of 1 cent. Earnings, adjusted for non-recurring costs, were 14 cents per share. The results surpassed Wall Street ...